{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:20:15Z","timestamp":1791534015031,"version":"4.3.4"},"reference-count":150,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>As the clinical course of autosomal recessive limb\u2013girdle muscular dystrophy (LGMDR) is highly variable, this study characterized the frequency of loss of ambulation (LOA) among patients by subtype (LGMDR1, LGMDR2, LGMDR3\u20136, LGMDR9, LGMDR12) and progression to cardiac and respiratory involvement among those with and without LOA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Systematic literature review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From 2929 abstracts screened, 418 patients were identified with ambulatory status data (LOA: 265 [63.4%]). Cardiac and\/or respiratory function was reported for 142 patients (34.0%; all with LOA). Among these, respiratory involvement was most frequent in LGMDR3\u20136 (74.1%; mean [SD] age 23.9 [11.0] years) and cardiac in LGMDR9 (73.3%; mean [SD] age 23.7 [17.7] years). Involvement was less common in patients without LOA except in LGMDR9 (71.4% respiratory and 52.4% cardiac).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This study described the co-occurrence of LOA, cardiac, and respiratory involvement in LGMDR and provides greater understanding of the clinical progression of LGMDR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0000000000000461","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T13:05:07Z","timestamp":1699967107000},"page":"65-80","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Patterns of Clinical Progression Among Patients With Autosomal Recessive Limb-Girdle Muscular Dystrophy: A Systematic Review"],"prefix":"10.1097","volume":"25","author":[{"given":"Antoinette","family":"Cheung","sequence":"first","affiliation":[{"name":"Broadstreet HEOR, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana F.","family":"Audhya","sequence":"additional","affiliation":[{"name":"Sarepta Therapeutics Inc, Cambridge MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelagh M.","family":"Szabo","sequence":"additional","affiliation":[{"name":"Broadstreet HEOR, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friesen","sequence":"additional","affiliation":[{"name":"Broadstreet HEOR, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad C.","family":"Weihl","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Gooch","sequence":"additional","affiliation":[{"name":"Sarepta Therapeutics Inc, Cambridge MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250507","first-page":"1599","article-title":"The limb-girdle muscular dystrophies","volume":"25","author":"Wicklund","year":"2019","journal-title":"Continuum"},{"key":"R2-20250507","first-page":"207","article-title":"LGMD. Identification, description and classification","volume":"39","author":"Angelini","year":"2020","journal-title":"Acta Myol."},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-0037-1601860","article-title":"Dystrophinopathies and limb-girdle muscular dystrophies","volume":"48","author":"Sarkozy","year":"2017","journal-title":"Neuropediatrics"},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.25192","article-title":"The Italian limb girdle muscular dystrophy registry: relative frequency, clinical features, and differential diagnosis","volume":"55","author":"Magri","year":"2017","journal-title":"Muscle Nerve"},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1002\/jcp.27907","article-title":"Prevalence, pathological mechanisms, and genetic basis of limb-girdle muscular dystrophies: a review","volume":"234","author":"Taghizadeh","year":"2019","journal-title":"J Cell Physiol."},{"key":"R7-20250507","first-page":"1954","article-title":"The limb-girdle muscular dystrophies and the dystrophinopathies","volume":"22","author":"Iyadurai","year":"2016","journal-title":"Continuum"},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/acn3.51042","article-title":"Global FKRP registry: observations in more than 300 patients with limb girdle muscular dystrophy R9","volume":"7","author":"Murphy","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"R10-20250507","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13023-019-1291-2","article-title":"The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease","volume":"15","author":"Bevilacqua","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"R11-20250507","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nmd.2021.01.009","article-title":"Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease","volume":"31","author":"Moore","year":"2021","journal-title":"Neuromuscul Disord."},{"key":"R12-20250507","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/01677063.2017.1346093","article-title":"LGMD2E is the most common type of sarcoglycanopathies in the Iranian population","volume":"31","author":"Alavi","year":"2017","journal-title":"J Neurogenet."},{"key":"R13-20250507","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/BMR-181129","article-title":"Limb-girdle muscular dystrophy type 2B: an unusual cause of proximal muscular weakness in Saudi Arabia","volume":"31","author":"Algahtani","year":"2018","journal-title":"J Back Musculoskelet Rehabil."},{"key":"R14-20250507","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.nmd.2017.02.015","article-title":"Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated alpha-dystroglycan levels in patients homozygous for common FKRP mutation","volume":"27","author":"Alhamidi","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"R15-20250507","first-page":"277","article-title":"LGMD2D syndrome: the importance of clinical and molecular genetics in patient and family management. Case Report","volume":"37","author":"Al-Harbi","year":"2016","journal-title":"Neuro Endocrinol Lett."},{"key":"R16-20250507","first-page":"127","article-title":"Dysferlinopathy course and sportive activity: clues for possible treatment","volume":"30","author":"Angelini","year":"2011","journal-title":"Acta Myol."},{"key":"R17-20250507","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1212\/WNL.57.2.271","article-title":"Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy","volume":"57","author":"Aoki","year":"2001","journal-title":"Neurology"},{"key":"R18-20250507","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/brain\/123.6.1229","article-title":"Muscular dystrophy due to dysferlin deficiency in Libyan Jews","volume":"123","author":"Argov","year":"2000","journal-title":"Brain"},{"key":"R19-20250507","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mus.26189","article-title":"Multiparametric quantitative MRI assessment of thigh muscles in limb-girdle muscular dystrophy 2A and 2B","volume":"58","author":"Arrigoni","year":"2018","journal-title":"Muscle Nerve"},{"key":"R20-20250507","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jmg.37.2.102","article-title":"Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations","volume":"37","author":"Barresi","year":"2000","journal-title":"J Med Genet."},{"key":"R21-20250507","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nmd.2008.11.010","article-title":"Eosinophilic myositis as presenting symptom in gamma-sarcoglycanopathy","volume":"19","author":"Baumeister","year":"2009","journal-title":"Neuromuscul Disord."},{"key":"R22-20250507","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/archneur.62.12.1894","article-title":"Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I","volume":"62","author":"Boito","year":"2005","journal-title":"Arch Neurol."},{"key":"R23-20250507","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/5.12.1953","article-title":"Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E)","volume":"5","author":"Bonnemann","year":"1996","journal-title":"Hum Mol Genet."},{"key":"R24-20250507","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neurol.2011.10.005","article-title":"Miyoshi-like distal myopathy with mutations in anoctamin 5 gene","volume":"168","author":"Bouquet","year":"2012","journal-title":"Rev Neurol."},{"key":"R25-20250507","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0960-8966(00)00207-8","article-title":"Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria","volume":"11","author":"Cagliani","year":"2001","journal-title":"Neuromuscul Disord."},{"key":"R26-20250507","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0960-8966(03)00133-0","article-title":"Molecular analysis of LGMD-2B and MM patients: identification of novel DYSF mutations and possible founder effect in the Italian population","volume":"13","author":"Cagliani","year":"2003","journal-title":"Neuromuscul Disord."},{"key":"R27-20250507","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/humu.9364","article-title":"Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies","volume":"26","author":"Cagliani","year":"2005","journal-title":"Hum Mutat."},{"key":"R28-20250507","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.nmd.2019.06.005","article-title":"Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy","volume":"29","author":"Cai","year":"2019","journal-title":"Neuromuscul Disord."},{"key":"R29-20250507","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0960-8966(00)00147-4","article-title":"Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients","volume":"10","author":"Calvo","year":"2000","journal-title":"Neuromuscul Disord."},{"key":"R30-20250507","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nmd.2007.09.013","article-title":"Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy","volume":"18","author":"D'Amico","year":"2008","journal-title":"Neuromuscul Disord."},{"key":"R31-20250507","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejpn.2007.02.018","article-title":"Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I","volume":"11","author":"Darin","year":"2007","journal-title":"Eur J Paediatric Neurol."},{"key":"R32-20250507","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.ejhg.5201066","article-title":"Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum","volume":"11","author":"de Paula","year":"2003","journal-title":"Eur J Hum Genet."},{"key":"R33-20250507","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/CND.0000000000000018","article-title":"Puerto rican founder mutation G787A in the SGCG Gene: a case report of 2 siblings with LGMD 2C","volume":"15","author":"Dicapua","year":"2014","journal-title":"J Clin Neuromuscul Dis."},{"key":"R34-20250507","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmg.37.5.361","article-title":"A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families","volume":"37","author":"Dincer","year":"2000","journal-title":"J Med Genet."},{"key":"R35-20250507","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0887-8994(00)00262-9","article-title":"Limb girdle muscular dystrophy type 2A presenting with cardiac arrest","volume":"24","author":"Di\u0307ri\u0307k","year":"2001","journal-title":"Pediatr Neurol."},{"key":"R36-20250507","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0960-8966(00)00099-7","article-title":"A new locus for autosomal recessive limb-girdle muscular dystrophy in a large consanguineous Tunisian family maps to chromosome 19q13.3","volume":"10","author":"Driss","year":"2000","journal-title":"Neuromuscul Disord."},{"key":"R37-20250507","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0960-8966(02)00280-8","article-title":"LGMD2E patients risk developing dilated cardiomyopathy","volume":"13","author":"Fanin","year":"2003","journal-title":"Neuromuscul Disord."},{"key":"R38-20250507","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2015.11.009","article-title":"Dysferlinopathy in Iran: clinical and genetic report","volume":"359","author":"Fatehi","year":"2015","journal-title":"J Neurol Sci."},{"key":"R39-20250507","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mus.26169","article-title":"Fatty infiltration evaluation and selective pattern characterization of lower limbs in limb-girdle muscular dystrophy type 2A by muscle magnetic resonance imaging","volume":"58","author":"Feng","year":"2018","journal-title":"Muscle Nerve"},{"key":"R40-20250507","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0960-8966(01)00245-0","article-title":"Myopathy with lobulated muscle fibers: evidence for heterogeneous etiology and clinical presentation","volume":"12","author":"Figarella-Branger","year":"2002","journal-title":"Neuromuscul Disord."},{"key":"R41-20250507","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00415-005-0684-4","article-title":"Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs","volume":"252","author":"Fischer","year":"2005","journal-title":"J Neurol."},{"key":"R42-20250507","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/sj.ejhg.5201436","article-title":"Hutterite brothers both affected with two forms of limb girdle muscular dystrophy: LGMD2H and LGMD2I","volume":"13","author":"Frosk","year":"2005","journal-title":"Eur J Hum Genet."},{"key":"R43-20250507","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/jhg.2016.94","article-title":"FKRP mutations, including a founder mutation, cause phenotype variability in Chinese patients with dystroglycanopathies","volume":"61","author":"Fu","year":"2016","journal-title":"J Hum Genet."},{"key":"R44-20250507","first-page":"1091","article-title":"Severe respiratory and skeletal muscles involvement in a carrier of dysferlinopathy with chronic obstructive pulmonary disease","volume":"55","author":"Fuschillo","year":"2010","journal-title":"Respir Care"},{"key":"R45-20250507","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00415-006-0213-0","article-title":"Cardiac involvement in limb-girdle muscular dystrophy 2I: conventional cardiac diagnostic and cardiovascular magnetic resonance","volume":"253","author":"Gaul","year":"2006","journal-title":"J Neurol."},{"key":"R46-20250507","first-page":"57","article-title":"Limb girdle muscular dystrophy type 2E due to a novel large deletion in SGCB gene","volume":"11","author":"Ghafouri-Fard","year":"2017","journal-title":"Iran J Child Neurol."},{"key":"R47-20250507","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s004150070151","article-title":"Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy","volume":"247","author":"Ginjaar","year":"2000","journal-title":"J Neurol."},{"key":"R48-20250507","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mus.26403","article-title":"Disease duration and disability in dysfeRlinopathy can be described by muscle imaging using heatmaps and random forests","volume":"59","author":"Gomez-Andres","year":"2019","journal-title":"Muscle Nerve"},{"key":"R49-20250507","first-page":"1077","article-title":"Gamma-Sarcoglycanopathy","volume":"40","author":"Gulati","year":"2003","journal-title":"Indian Pediatr."},{"key":"R50-20250507","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/j.clinph.2017.06.128","article-title":"P 49 A slight change with a major impact\u2014a report on a patient with limb girdle muscular dystrophy","volume":"128","author":"Habig","year":"2017","journal-title":"Clin Neurophysiol."},{"key":"R51-20250507","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/eurjhf\/hft057","article-title":"Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I","volume":"15","author":"Hollingsworth","year":"2013","journal-title":"Eur J Heart Fail."},{"key":"R52-20250507","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jocn.2010.08.010","article-title":"Asian patients with limb girdle muscular dystrophy 2I (LGMD2I)","volume":"18","author":"Hong","year":"2011","journal-title":"J Clin Neurosci."},{"key":"R53-20250507","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.wnl.0000256768.79353.60","article-title":"Symptomatic dysferlin gene mutation carriers: characterization of two cases","volume":"68","author":"Illa","year":"2007","journal-title":"Neurology"},{"key":"R54-20250507","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.ajkd.2006.04.074","article-title":"Loss of podocyte dysferlin expression is associated with minimal change nephropathy","volume":"48","author":"Izzedine","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"R55-20250507","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1546-0096-11-19","article-title":"Limb girdle muscular dystrophy type 2B masquerading as inflammatory myopathy: case report","volume":"11","author":"Jethwa","year":"2013","journal-title":"Pediatr Rheumatol."},{"key":"R56-20250507","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1297\/cpe.18.51","article-title":"Isolated neurosarcoidosis revealed by diabetes insipidus, visual loss and diplopia in a child patient: a diagnostic problem","volume":"18","author":"Jomaa","year":"2009","journal-title":"Clin Pediatr Endocrinol."},{"key":"R57-20250507","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2474-8-115","article-title":"LGMD2I in a North American population","volume":"8","author":"Kang","year":"2007","journal-title":"BMC Musculoskelet Disord."},{"key":"R58-20250507","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02760585","article-title":"Beta-sarcoglycanopathy","volume":"72","author":"Kapoor","year":"2005","journal-title":"Indian J Pediatr."},{"key":"R59-20250507","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2008-1081465","article-title":"Variable cardiac involvement in Tunisian siblings harboring FKRP gene mutations","volume":"39","author":"Kefi","year":"2008","journal-title":"Neuropediatrics"},{"key":"R60-20250507","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/0028-3886.43459","article-title":"Twenty-two year follow-up of an Indian family with dysferlinopathy-clinical, immunocytochemical, western blotting and genetic features","volume":"56","author":"Khadilkar","year":"2008","journal-title":"Neurol India"},{"key":"R61-20250507","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.nmd.2008.01.004","article-title":"Late onset in dysferlinopathy widens the clinical spectrum","volume":"18","author":"Klinge","year":"2008","journal-title":"Neuromuscul Disord."},{"key":"R62-20250507","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/RHU.0000000000000126","article-title":"Late-onset dysferlinopathy presented as \"liver Enzyme\" abnormalities: a technical note","volume":"20","author":"Li","year":"2014","journal-title":"J Clin Rheumatol."},{"key":"R63-20250507","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/ene.12191","article-title":"ANO5-muscular dystrophy: clinical, pathological and molecular findings","volume":"20","author":"Liewluck","year":"2013","journal-title":"Eur J Neurol."},{"key":"R64-20250507","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.braindev.2006.09.006","article-title":"A novel FKRP gene mutation in a Taiwanese patient with limb-girdle muscular dystrophy 2I","volume":"29","author":"Lin","year":"2007","journal-title":"Brain Dev."},{"key":"R65-20250507","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1600-0404.2011.01608.x","article-title":"Episodes of exercise-induced dark urine and myalgia in LGMD 2I","volume":"125","author":"Lindberg","year":"2011","journal-title":"Acta Neurol Scand."},{"key":"R66-20250507","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mus.23542","article-title":"Novel mutations in the anoctamin 5 gene (ANO5) associated with limb-girdle muscular dystrophy 2L","volume":"47","author":"Little","year":"2013","journal-title":"Muscle Nerve"},{"key":"R67-20250507","doi-asserted-by":"crossref","first-page":"e1106","DOI":"10.1002\/cnr2.1106","article-title":"Chemotherapy dosing and toxicity in a patient with muscular dystrophy","volume":"1","author":"Lomma","year":"2018","journal-title":"Cancer Rep."},{"key":"R68-20250507","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/mus.21432","article-title":"Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I","volume":"40","author":"Margeta","year":"2009","journal-title":"Muscle Nerve"},{"key":"R69-20250507","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jocn.2018.04.025","article-title":"A novel CAPN3 mutation in late-onset limb-girdle muscular dystrophy with early respiratory insufficiency","volume":"53","author":"Martinez-Thompson","year":"2018","journal-title":"J Clin Neurosci."},{"key":"R70-20250507","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/ced.12774","article-title":"Isotretinoin treatment of autosomal recessive congenital ichthyosis complicated by coexisting dysferlinopathy","volume":"41","author":"Mashiah","year":"2016","journal-title":"Clin Exp Dermatol."},{"key":"R71-20250507","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1468-1331.2007.01808.x","article-title":"A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene","volume":"14","author":"Matsubara","year":"2007","journal-title":"Eur J Neurol."},{"key":"R72-20250507","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mus.21222","article-title":"Homozygous contiguous gene deletion of 13q12 causing LGMD2C and ARSACS in the same patient","volume":"39","author":"McMillan","year":"2009","journal-title":"Muscle Nerve"},{"key":"R73-20250507","first-page":"1040","article-title":"Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation","volume":"59","author":"McNally","year":"1996","journal-title":"Am J Hum Genet."},{"key":"R74-20250507","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.22251","article-title":"Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D","volume":"68","author":"Mendell","year":"2010","journal-title":"Ann Neurol."},{"key":"R75-20250507","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ana.10559","article-title":"Phenotypic spectrum associated with mutations in the fukutin-related protein gene","volume":"53","author":"Mercuri","year":"2003","journal-title":"Ann Neurol."},{"key":"R76-20250507","first-page":"58","article-title":"Cardiomyopathy in a patient with limb-girdle muscular dystrophy type 2D: pathomorphological aspects","volume":"1","author":"Meznaric-Petrusa","year":"2009","journal-title":"Forensic Sci Int Suppl Ser."},{"key":"R77-20250507","doi-asserted-by":"crossref","first-page":"e004960","DOI":"10.1161\/CIRCHEARTFAILURE.118.004960","article-title":"Advanced dilated cardiomyopathy in a patient with hutterite limb-girdle muscular dystrophy: use of a left ventricular assist device","volume":"11","author":"Miskew Nichols","year":"2018","journal-title":"Circ Heart Fail."},{"key":"R78-20250507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01677063.2016.1141208","article-title":"A rare form of limb girdle muscular dystrophy (type 2E) seen in an Iranian family detected by autozygosity mapping","volume":"30","author":"Mojbafan","year":"2016","journal-title":"J Neurogenet."},{"key":"R79-20250507","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.nmd.2005.02.004","article-title":"Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation","volume":"15","author":"Muller","year":"2005","journal-title":"Neuromuscul Disord."},{"key":"R80-20250507","first-page":"77","article-title":"Sarcoglycanopathy\u2014a rare case report and literature review","volume":"15","author":"Mustafa","year":"2014","journal-title":"J Med (Bangladesh)"},{"key":"R81-20250507","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1789.2004.00573.x","article-title":"Dysferlinopathy associated with rigid spine syndrome","volume":"24","author":"Nagashima","year":"2004","journal-title":"Neuropathology"},{"key":"R82-20250507","doi-asserted-by":"crossref","first-page":"685","DOI":"10.21037\/qims.2017.10.09","article-title":"Left ventricular deformation abnormalities in a patient with calpainopathy\u2014a case from the three-dimensional speckle-tracking echocardiographic magyar-path study","volume":"7","author":"Nemes","year":"2017","journal-title":"Quant Imaging Med Surg."},{"key":"R83-20250507","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0960-8966(99)00063-2","article-title":"Severe gamma-sarcoglycanopathy caused by a novel missense mutation and a large deletion","volume":"10","author":"Nowak","year":"2000","journal-title":"Neuromuscul Disord."},{"key":"R84-20250507","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2007-973744","article-title":"Neurosensory hearing loss in secondary adhalinopathy","volume":"27","author":"Oexle","year":"1996","journal-title":"Neuropediatrics"},{"key":"R85-20250507","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1161\/CIRCHEARTFAILURE.112.971424","article-title":"A cardiomyopathy in a patient with limb girdle muscular dystrophy type 2A","volume":"6","author":"Okere","year":"2013","journal-title":"Circ Heart Fail."},{"key":"R86-20250507","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.nmd.2018.09.009","article-title":"Severe limb-girdle muscular dystrophy 2A in two young siblings from Guinea-Bissau associated with a novel null homozygous mutation in CAPN3 gene","volume":"28","author":"Oliveira Santos","year":"2018","journal-title":"Neuromuscul Disord."},{"key":"R87-20250507","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.0b013e3181ea1564","article-title":"Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies","volume":"75","author":"Paradas","year":"2010","journal-title":"Neurology"},{"key":"R88-20250507","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3346\/jkms.2012.27.4.424","article-title":"Heterogeneous characteristics of Korean patients with dysferlinopathy","volume":"27","author":"Park","year":"2012","journal-title":"J Korean Med Sci."},{"key":"R89-20250507","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jmg.33.2.97","article-title":"Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families","volume":"33","author":"Passos-Bueno","year":"1996","journal-title":"J Med Genet."},{"key":"R90-20250507","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/(SICI)1097-4598(199808)21:8<1078::AID-MUS15>3.0.CO;2-Q","article-title":"Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblings","volume":"21","author":"Penisson-Besnier","year":"1998","journal-title":"Muscle Nerve"},{"key":"R91-20250507","first-page":"163","article-title":"Phenotypic and genetic spectrum of patients with limb-girdle muscular dystrophy type 2A from Serbia","volume":"38","author":"Peric","year":"2019","journal-title":"Acta Myol."},{"key":"R92-20250507","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12883-015-0449-3","article-title":"Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects","volume":"15","author":"Petersen","year":"2015","journal-title":"BMC Neurol."},{"key":"R93-20250507","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1590\/S0004-282X2008000100019","article-title":"Limb-girdle muscular dystrophy type 2B mimicking polymyositis","volume":"66","author":"Pimentel","year":"2008","journal-title":"Arquivos de Neuro-Psiquiatria"},{"key":"R94-20250507","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0960-8966(00)00197-8","article-title":"The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach","volume":"11","author":"Pollitt","year":"2001","journal-title":"Neuromuscul Disord."},{"key":"R95-20250507","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/01.WNL.0000058902.88181.3D","article-title":"The phenotype of limb-girdle muscular dystrophy type 2I","volume":"60","author":"Poppe","year":"2003","journal-title":"Neurology"},{"key":"R96-20250507","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s004010050926","article-title":"Sarcoglycan deficiency in a large Italian population of myopathic patients","volume":"96","author":"Prelle","year":"1998","journal-title":"Acta Neuropathologica"},{"key":"R97-20250507","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/mus.24717","article-title":"Evaluation of heart involvement in calpainopathy (LGMD2A) using cardiovascular magnetic resonance","volume":"52","author":"Quick","year":"2015","journal-title":"Muscle Nerve"},{"key":"R98-20250507","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1469-8749.1997.tb07381.x","article-title":"Absence of alpha-sarcoglycan and novel missense mutations in the alpha-sarcoglycan gene in a young British girl with muscular dystrophy","volume":"39","author":"Quinlivan","year":"2008","journal-title":"Dev Med Child Neurol."},{"key":"R99-20250507","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/apa.12561","article-title":"Clinical and muscle biopsy findings in Norwegian paediatric patients with limb girdle muscular dystrophy 2I","volume":"103","author":"Rasmussen","year":"2014","journal-title":"Acta Paediatr."},{"key":"R100-20250507","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12031-019-01383-z","article-title":"Novel missense CAPN3 mutation responsible for adult-onset limb girdle muscular dystrophy with calves hypertrophy","volume":"69","author":"Rekik","year":"2019","journal-title":"J Mol Neurosci."},{"key":"R101-20250507","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nmd.2011.11.005","article-title":"Cortical heterotopia in LGMD2I","volume":"22","author":"Renard","year":"2012","journal-title":"Neuromuscul Disord."},{"key":"R102-20250507","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.21650","article-title":"Novel diagnostic features of dysferlinopathies","volume":"42","author":"Rosales","year":"2010","journal-title":"Muscle Nerve"},{"key":"R103-20250507","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1532-429X-13-39","article-title":"Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I","volume":"13","author":"Rosales","year":"2011","journal-title":"J Cardiovasc Magn Reson."},{"key":"R104-20250507","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mus.22194","article-title":"Does the severity of the LGMD2A phenotype in compound heterozygotes depend on the combination of mutations?","volume":"44","author":"Saenz","year":"2011","journal-title":"Muscle Nerve"},{"key":"R105-20250507","first-page":"143","article-title":"A case of bilateral scapular winging","volume":"20","author":"Sahai","year":"2019","journal-title":"J Clin Neuromuscul Dis."},{"key":"R106-20250507","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/mus.23281","article-title":"Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and miyoshi type of muscular dystrophy","volume":"45","author":"Schessl","year":"2012","journal-title":"Muscle Nerve"},{"key":"R107-20250507","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fnins.2017.00449","article-title":"Treadmill training with HAL exoskeleton-A novel approach for symptomatic therapy in patients with limb-girdle muscular dystrophy-preliminary study","volume":"11","author":"Sczesny-Kaiser","year":"2017","journal-title":"Front Neurosci."},{"key":"R108-20250507","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2006.01.005","article-title":"Muscle inflammation, autoimmune Addison's disease and sarcoidosis in a patient with dysferlin deficiency","volume":"16","author":"Selva-O'Callaghan","year":"2006","journal-title":"Neuromuscul Disord."},{"key":"R109-20250507","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fneur.2019.00619","article-title":"Limb-Girdle Muscular Dystrophies (LGMDs): the clinical application of NGS analysis, a family case report","volume":"10","author":"Strafella","year":"2019","journal-title":"Front Neurol."},{"key":"R110-20250507","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5114\/fn.2014.47847","article-title":"Of an adolescent girl with limb-girdle muscular dystrophy type 2B\u2014the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies","volume":"4","author":"Szymanska","year":"2014","journal-title":"Folia Neuropathol."},{"key":"R111-20250507","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1212\/01.WNL.0000068333.43005.12","article-title":"Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype","volume":"60","author":"Takahashi","year":"2003","journal-title":"Neurology"},{"key":"R112-20250507","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<807::AID-MUS20>3.0.CO;2-0","article-title":"Intrafamilial phenotypic variation in limb-girdle muscular dystrophy type 2C with compound heterozygous mutations","volume":"23","author":"Takano","year":"2000","journal-title":"Muscle Nerve"},{"key":"R113-20250507","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.nmd.2015.09.010","article-title":"Alpha-sarcoglycanopathy presenting as exercise intolerance and rhabdomyolysis in two adults","volume":"25","author":"Tarnopolsky","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"R114-20250507","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jnnp-2017-316736","article-title":"MRI in sarcoglycanopathies: a large international cohort study","volume":"89","author":"Tasca","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R115-20250507","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1017\/S0317167100054135","article-title":"Founder mutation for a-sarcoglycan-LGMD2D in a magdalen islands acadian cluster","volume":"38","author":"Tetreault","year":"2011","journal-title":"Can J Neurol Sci."},{"key":"R116-20250507","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10048-007-0083-3","article-title":"A large deletion and novel point mutations in the calpain 3 gene (CAPN3) in Bulgarian LGMD2A patients","volume":"8","author":"Todorova","year":"2007","journal-title":"Neurogenetics"},{"key":"R117-20250507","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-2007-973702","article-title":"Calpain-3 deficiency causes a mild muscular dystrophy in childhood","volume":"28","author":"Topalo\u01e7lu","year":"1997","journal-title":"Neuropediatrics"},{"key":"R118-20250507","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1440-1789.2011.01221.x","article-title":"Lobulated fibers in a patient with 46-year history of limb-girdle muscle weakness","volume":"31","author":"Tsuburaya","year":"2011","journal-title":"Neuropathology"},{"key":"R119-20250507","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0960-8966(00)00168-1","article-title":"A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy","volume":"11","author":"Ueyama","year":"2001","journal-title":"Neuromuscul Disord."},{"key":"R120-20250507","first-page":"145","article-title":"Corrigendum: twenty-year clinical progression of dysferlinopathy in patients from dagestan","volume":"8","author":"Umakhanova","year":"2017","journal-title":"Front Neurol."},{"key":"R121-20250507","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<984::AID-MUS24>3.0.CO;2-#","article-title":"Partial \u03b1\u2010sarcoglycan deficiency with retention of the dystrophin\u2010glycoprotein complex in a LGMD2D family","volume":"23","author":"Vainzof","year":"2000","journal-title":"Muscle Nerve"},{"key":"R122-20250507","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0960-8966(98)00040-6","article-title":"A novel gamma-sarcoglycan mutation causing childhood onset, slowly progressive limb girdle muscular dystrophy","volume":"8","author":"Van der Kooi","year":"1998","journal-title":"Neuromuscul Disord."},{"key":"R123-20250507","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nmd.2013.03.012","article-title":"ANO5 mutations in the Dutch limb girdle muscular dystrophy population","volume":"23","author":"Van der Kooi","year":"2013","journal-title":"Neuromuscul Disord."},{"key":"R124-20250507","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00431-005-1752-6","article-title":"Limb girdle muscular dystrophy type 2I caused by a novel missense mutation in the FKRP gene presenting as acute virus-associated myositis in infancy","volume":"165","author":"Von Der Hagen","year":"2006","journal-title":"Eur J Pediatr."},{"issue":"suppl 3","key":"R125-20250507","first-page":"583","article-title":"Limb-girdle muscular dystrophy type 2i (LGMD2I) and dilated cardiomyopathy: management during Pregna","volume":"143","author":"Von Guionneau","year":"2018","journal-title":"Int J Gynecol Obstet."},{"key":"R126-20250507","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1097-4598(200103)24:3<421::AID-MUS1016>3.0.CO;2-R","article-title":"Isolated loss of gamma-sarcoglycan: diagnostic implications in autosomal recessive limb-girdle muscular dystrophies","volume":"24","author":"Vorgerd","year":"2001","journal-title":"Muscle Nerve"},{"key":"R127-20250507","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.nmd.2008.06.365","article-title":"Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study","volume":"18","author":"Wahbi","year":"2008","journal-title":"Neuromuscul Disord."},{"key":"R128-20250507","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/mus.22041","article-title":"Progressive dysphagia in limb-girdle muscular dystrophy type 2B","volume":"43","author":"Walsh","year":"2011","journal-title":"Muscle Nerve"},{"key":"R129-20250507","first-page":"1","article-title":"Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood","volume":"23","author":"Walter","year":"2004","journal-title":"Acta Myol."},{"key":"R130-20250507","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-8-26","article-title":"Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial","volume":"8","author":"Walter","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"R131-20250507","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pedneo.2013.01.018","article-title":"Limb-girdle muscular dystrophy type 2A with mutation in CAPN3: the first report in Taiwan","volume":"56","author":"Wang","year":"2015","journal-title":"Pediatr Neonatal."},{"key":"R132-20250507","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00207454.2017.1380640","article-title":"Limb-girdle muscular dystrophy type 2I: two Chinese families and a review in Asian patients","volume":"128","author":"Wang","year":"2018","journal-title":"Int J Neurosci."},{"key":"R133-20250507","doi-asserted-by":"crossref","first-page":"e90377","DOI":"10.1371\/journal.pone.0090377","article-title":"Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study","volume":"9","author":"Willis","year":"2014","journal-title":"PLoS One"},{"key":"R134-20250507","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nmd.2009.11.005","article-title":"Two siblings with limb-girdle muscular dystrophy type 2E responsive to deflazacort","volume":"20","author":"Wong-Kisiel","year":"2010","journal-title":"Neuromuscul Disord."},{"key":"R135-20250507","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mus.24685","article-title":"Toward an objective measure of functional disability in dysferlinopathy","volume":"53","author":"Woudt","year":"2016","journal-title":"Muscle Nerve"},{"key":"R136-20250507","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4103\/0028-3886.149386","article-title":"Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy","volume":"62","author":"Xi","year":"2014","journal-title":"Neurol India"},{"key":"R137-20250507","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13023-019-1021-9","article-title":"Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients","volume":"14","author":"Xie","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"R138-20250507","first-page":"1","article-title":"Magnetic resonance imaging findings in the muscle tissue of patients with limb girdle muscular dystrophy type 2I harboring the founder mutation c.545A>G in the FKRP gene","volume":"2018","author":"Xie","year":"2018","journal-title":"Biomed Res Int."},{"key":"R139-20250507","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jmri.21905","article-title":"Cardiovascular magnetic resonance reveals similar damage to the heart of patients with Becker and limb-girdle muscular dystrophy but no cardiac symptoms","volume":"30","author":"Yilmaz","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"R140-20250507","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3233\/JND-160186","article-title":"Decreased aerobic capacity in ANO5-muscular dystrophy","volume":"3","author":"Ylikallio","year":"2016","journal-title":"J Neuromuscul Dis."},{"key":"R141-20250507","doi-asserted-by":"crossref","first-page":"e0175343","DOI":"10.1371\/journal.pone.0175343","article-title":"Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing","volume":"12","author":"Yu","year":"2017","journal-title":"PLoS One"},{"key":"R142-20250507","first-page":"161","article-title":"A rare form of limb-girdle muscular dystrophy (LGMD type 2E) in trisomy 21","volume":"37","author":"Yuksel","year":"2018","journal-title":"Acta Myologica"},{"key":"R143-20250507","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JND-210771","article-title":"Progression to loss of ambulation among patients with autosomal recessive limb-girdle muscular dystrophy: a systematic review","volume":"9","author":"Audhya","year":"2022","journal-title":"J Neuromuscul Dis."},{"key":"R144-20250507","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s10930-021-10006-9","article-title":"A journey with LGMD: from protein abnormalities to patient impact","volume":"40","author":"Georganopoulou","year":"2021","journal-title":"Protein J."},{"key":"R145-20250507","doi-asserted-by":"crossref","first-page":"e0153095","DOI":"10.1371\/journal.pone.0153095","article-title":"Natural history of cardiac and respiratory involvement, prognosis and predictive factors for long-term survival in adult patients with limb girdle muscular dystrophies type 2C and 2D","volume":"11","author":"Fayssoil","year":"2016","journal-title":"PLoS One"},{"key":"R146-20250507","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/brain\/awaa228","article-title":"New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy","volume":"143","author":"Alonso-P\u00e9rez","year":"2020","journal-title":"Brain"},{"key":"R147-20250507","doi-asserted-by":"crossref","first-page":"657949","DOI":"10.3389\/fneur.2021.657949","article-title":"Clinical determinants of disease progression in patients with beta-sarcoglycan gene mutations","volume":"12","author":"Marchetti","year":"2021","journal-title":"Front Neurol."},{"key":"R148-20250507","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/nmt-2020-0066","article-title":"Unmet needs and evolving treatment for limb girdle muscular dystrophies","volume":"11","author":"Pozsgai","year":"2021","journal-title":"Neurodegenerative Dis Manage."},{"key":"R149-20250507","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1212\/WNL.0000000000200708","article-title":"Prospective natural history study in 24 adult patients with LGMDR12 over 2 Years of follow-up: quantitative MRI and clinical outcome measures","volume":"99","author":"De Wel","year":"2022","journal-title":"Neurology"},{"key":"R150-20250507","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10048-022-00707-3","article-title":"Genotype-phenotype correlation and natural history study of dysferlinopathy: a single-centre experience from India","volume":"24","author":"Nashi","year":"2022","journal-title":"Neurogenetics"},{"key":"R151-20250507","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid Based Med."},{"key":"R152-20250507","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/brain\/awq294","article-title":"A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy","volume":"134","author":"Hicks","year":"2011","journal-title":"Brain"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:03:22Z","timestamp":1746651802000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":150,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000461","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}